Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1989-12-15
1991-10-29
Shah, Hukund J.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
544354, 558411, 558417, 558418, 560 13, 560 22, 560 43, 564 87, 564442, 568306, A61K 31495, C07D24144
Patent
active
050617060
ABSTRACT:
Heterocyclic dihydroxyquinoxaline compounds having the formula ##STR1## wherein R.sup.1 is hydroxy, alkoxy, aryloxy, aralkyloxy, cycloalkylalkoxy, cycloalkoxy, or acyloxy; and
REFERENCES:
patent: 3992378 (1976-11-01), St. Clair et al.
patent: 4812458 (1989-03-01), Honore et al.
Page et al. Chemical Abstracts, vol. 86, No. 114929 (1977) (Abstract for Xenobiotica, pp. 713-723 (1976.).
McFarlane et al., Chemical Abstracts, vol. 109, No. 110373 (1988) (Abstract for Tet. Lett. pp. 6363-6366 (1987).).
Page, J. G. et al. Xenobiotica, 1976, vol. 6, No. 12, pp. 713-723.
McFarlane, M. D. et al., Tetrahedron Letters, vol. 28, No. 50, pp. 6363-6366, 1987.
Honoree Tage
Jacobsen Poul
Nafrim Lars
Nielsen Flemming E.
Beinhardt E.
Lambiris Elias J.
Novo Nordisk A S
Shah Hukund J.
Zelson Steve T.
LandOfFree
2,3-quinoxalinediones for use as neuroleptics does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 2,3-quinoxalinediones for use as neuroleptics, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 2,3-quinoxalinediones for use as neuroleptics will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1400727